| Literature DB >> 32762417 |
Budheswar Dehury1, Vishakha Raina1, Namrata Misra1,2, Mrutyunjay Suar1,2.
Abstract
Recent studies have pointed the role of angiotensin-converting enzyme-II (ACE2) in mediating the entry of SARS-CoV-2 to the host cell by binding to the receptor-binding domain (RBD) of viral spike protein, and successive priming by cellular proteases initiates the infection. SARS-CoV replication rate and disease severity is controlled by the binding affinity of RBD with ACE2. To understand, how mutations in the conserved residues of RBD affect the molecular interaction with ACE2, we generated five alanine mutants i.e. Y449A, N487A, Y489A, N501A and Y505A in the receptor binding motif (RBM) of the ACE2-RBD SARS-CoV-2 complex (PDB: 6M0J). Computational site directed mutagenesis induced dynamics in wild-type and mutant complexes were extensively studied through all-atoms molecular dynamics (MD) simulations of 150 ns. In silico mutational analysis revealed loss of important intermolecular hydrogen bonds and other non-bonded contacts, critical for molecular recognition of SARS-CoV-2 RBD to ACE2, which is well supported by saturation mutagenesis study of binding interface residues. MD simulations results showed that RBM motif is flexible, where mutant residues are relatively more mobile than corresponding wild-type residues. Global motion analysis through principal component studies revealed that RBD exhibits protuberant in-ward motion towards the human ACE2 binding interface which may be crucial for molecular interaction. Conclusively, the present finding are in congruence with previous experimental reports and provides detailed information on the structural basis of receptor binding by human SARS-CoV-2, which will crucial for the development of novel inhibitors or drugs to combat against SARS-CoV-2.Communicated by Ramaswamy H. Sarma.Entities:
Keywords: MD simulation; SARS-CoV-2; angiotensin-converting enzyme-II; coronavirus; receptor binding motif
Mesh:
Substances:
Year: 2020 PMID: 32762417 PMCID: PMC7484587 DOI: 10.1080/07391102.2020.1802348
Source DB: PubMed Journal: J Biomol Struct Dyn ISSN: 0739-1102
Figure 1.Sequence-structure comparison of receptor binding domain (RBD) from SARS CoV-2 and SARS CoV and structural features of ACE2-RBD complex (6M0J: ACE2-RBD complex of SARS CoV-2 and 2AJF:ACE2-RBD complex of SARS CoV. (A) Pair-wise sequence structure alignment of RBD from of SARS Cov-2 and SARS CoV (B). Electrostatic properties of ACE2-RBD complexes using the experimental structure 6M0J and 2AJF (Blue, red, and white colors represent positively charged, negatively charged, and neutral surfaces, respectively). (C) Structural superimposed view of ACE2-RBD complexes displaying the receptor binding motif marked in pink (green: 6M0J; SARS-CoV-2 and cyan: 2AJF; SARS-CoV).
Figure 2.Schematic representation of the present work where point mutations are induced at Tyr449, Asn487, Tyr489, Asn501 and Tyr505 of the RBM in ACE2-RBD (SARS Cov-2) complex and subjected to all-atoms MD simulation.
Figure 3.Stability parameters of the wild type and mutant ACE2-RBD complexes over the course of the simulation. Backbone root mean square deviation (RMSD), root mean square fluctuation (RMSF) of Cα-atoms RBD and ACE2, and radius of gyration (Rg) of each system over the time scale of 150 ns.
Intrinsic dynamics stability statistics of wild type and mutant ACE2-RBD complexes during 150 ns MD (values within brackets represents the standard deviation).
| System | RMSD (nm) | Rg (nm) | SASA (nm2) | RMSF | ||
|---|---|---|---|---|---|---|
| ACE2 (nm) | RBD (nm) | RBM (nm) | ||||
| WT | 0.25 (0.03) | 3.18 (0.02) | 363.27 (4.16) | 0.14 (0.04) | 0.17 (0.06) | 0.16 |
| Y449A | 0.26 (0.03) | 3.21 (0.02) | 371.37 (3.15) | 0.21 (0.06) | 0.25 (0.05) | 0.28 |
| N487A | 0.26 (0.03) | 3.17 (0.03) | 365.27 (6.26) | 0.14 (0.04) | 0.21 (0.09) | 0.18 |
| Y489 | 0.30 (0.06) | 3.20 (0.03) | 368.92 (3.66) | 0.29 (0.09) | 0.32 (0.07) | 0.37 |
| N501A | 0.33 (0.09) | 3.37 (0.31) | 369.20 (4.08) | 0.34 (0.06) | 0.34 (0.08) | 0.40 |
| Y505A | 0.24 (0.04) | 3.20 (0.02) | 368.11 (4.37) | 0.15 (0.04) | 0.16 (0.06) | 0.13 |
Figure 4.Structural superimposition of the top ranked cluster representative of wild type and mutant ACE2-RBD complexes obtained from MD (shown in cyan) as compared to the experimental complex 6M0J (green).
Figure 5.Principal component analysis of the wild type and mutant RBD2-ACE2 complex systems using the last 100 ns trajectories. (A) Eigenvalues of each system (B) 2-Dimensional projection of top two eigenvectors (EV1 vs EV2) of each system in phase space. (C–H) Porcupine plot of the EV1 of each system displaying the movement of main-chain atoms where the cone represents the movements and length of cone displays the strength of movement.
Figure 6.The inter-molecular hydrogen bond dynamics of wild type and mutant RBD-ACE2 complexes during the last 100 ns MD.
Comparative analysis of hydrogen-bond and electrostatic contacts of wild type SARS-Cov-2 RBD with ACE2 (Experimental vs. MD simulation).
| 6M0J (RBD-ACE2 experimental complex) | MD simulated complex | ||||
|---|---|---|---|---|---|
| Interacting Pairs | Distance | Category | Interacting Pairs | Distance | Category |
| B:LYS417:NZ - A:ASP30:OD2 | 2.90 | Hydrogen Bond; Electrostatic | A:LYS31:NZ - B:GLU484:OE1 | 4.33 | Electrostatic |
| A:TYR41:OH - B:THR500:OG1 | 2.71 | Hydrogen Bond | A:LYS31:HZ2 - B:GLN493:OE1 | 2.03 | Hydrogen Bond |
| A:GLN42:NE2 - B:GLY446:O | 3.24 | Hydrogen Bond | A:GLN42:HE21 - B:GLN498:OE1 | 1.95 | Hydrogen Bond |
| A:GLN42:NE2 - B:TYR449:OH | 2.79 | Hydrogen Bond | A:TYR83:HH - B:ASN487:OD1 | 1.78 | Hydrogen Bond |
| A:TYR83:OH - B:ASN487:OD1 | 2.79 | Hydrogen Bond | B:GLN493:HE22 - A:GLU35:OE1 | 2.01 | Hydrogen Bond |
| A:LYS353:NZ - B:GLY496:O | 3.08 | Hydrogen Bond | B:GLN498:HE21 - A:GLN42:OE1 | 2.26 | Hydrogen Bond |
| B:TYR449:OH - A:ASP38:OD2 | 2.70 | Hydrogen Bond | B:THR500:HG1 - A:ASP355:OD2 | 1.91 | Hydrogen Bond |
| B:ASN487:ND2 - A:GLN24:OE1 | 2.69 | Hydrogen Bond | B:GLY502:HN - A:LYS353:O | 3.02 | Hydrogen Bond |
| B:GLN493:NE2:B - A:GLU35:OE1 | 3.13 | Hydrogen Bond | B:TYR505:HH - A:GLU37:OE1 | 1.72 | Hydrogen Bond |
| B:GLY502:N - A:LYS353:O | 2.78 | Hydrogen Bond | – | – | – |
A: ACE2 B: RBD.
Important hydrogen-bonds interaction observed in the mutant systems (the cluster representative of each system was used to compute the hydrogen bonds using BIOVIA DSV).
| Y449A | N487A | ||||
|---|---|---|---|---|---|
| Interacting Pairs | Distance | Category | Interacting Pairs | Distance | Category |
| B:LYS417:HZ2 - A:ASP30:OD2 | 1.65 | Hydrogen Bond; Electrostatic | B:LYS417:HZ3 - A:ASP30:OD2 | 1.64 | Hydrogen Bond; Electrostatic |
| B:ARG403:NH1 - A:GLU37:OE1 | 4.10 | Electrostatic | A:GLN24:HE21 - B:ALA475:O | 2.05 | Hydrogen Bond |
| B:LYS458:NZ - A:GLU23:OE1 | 4.82 | Electrostatic | B:THR500:HG1 - A:ASP355:OD2 | 1.61 | Hydrogen Bond |
| A:LYS31:HZ3 - B:GLN493:OE1 | 2.16 | Hydrogen Bond | B:GLY502:HN - A:LYS353:O | 2.10 | Hydrogen Bond |
| A:HIS34:HD1 - B:TYR453:OH | 1.77 | Hydrogen Bond | |||
| A:TYR83:HH - B:ASN487:OD1 | 1.96 | Hydrogen Bond | |||
| A:LYS353:HZ1 - B:GLY496:O | 2.07 | Hydrogen Bond | |||
| A:LYS353:HZ2 - B:GLN498:OE1 | 1.64 | Hydrogen Bond | |||
| B:ASN487:HD22 - A:GLN24:OE1 | 2.57 | Hydrogen Bond | |||
| B:GLN493:HE22 - A:GLU35:OE2 | 1.96 | Hydrogen Bond | |||
| B:THR500:HG1 - A:ASP355:OD2 | 1.63 | Hydrogen Bond | |||
| B:GLY502:HN - A:LYS353:O | 1.93 | Hydrogen Bond | |||
| B:TYR505:HH - A:GLU37:OE2 | 2.96 | Hydrogen Bond | |||
| A:GLN24:HE22 - B:GLN474:OE1 | 2.19 | Hydrogen Bond | B:LYS417:HZ2 - A:ASP30:OD2 | 1.61 | Hydrogen Bond; Electrostatic |
| A:LYS31:HZ1 - B:GLN493:OE1 | 2.65 | Hydrogen Bond | A:TYR83:HH - B:ASN487:OD1 | 1.82 | Hydrogen Bond |
| B:SER477:HG1 - A:THR20:OG1 | 2.88 | Hydrogen Bond | B:ASN487:HD21 - A:GLN24:OE1 | 2.14 | Hydrogen Bond |
| B:ASN487:HD22 - A:TYR83:OH | 2.20 | Hydrogen Bond | B:GLN493:HE22 - A:GLU35:OE1 | 2.01 | Hydrogen Bond |
| B:GLN493:HE22 - A:GLU35:OE1 | 2.29 | Hydrogen Bond | B:THR500:HG1 - A:ASP355:OD2 | 1.81 | Hydrogen Bond |
| B:THR500:HG1 - A:ASP355:OD2 | 2.46 | Hydrogen Bond | B:GLY502:HN - A:LYS353:O | 2.26 | Hydrogen Bond |
| B:GLY502:HN - A:LYS353:O | 2.46 | Hydrogen Bond | – | – | – |
| A:LYS31:HZ3 - B:GLU484:OE1 | 3.19 | Hydrogen Bond; Electrostatic | |||
| B:LYS417:HZ2 - A:ASP30:OD2 | 1.80 | Hydrogen Bond; Electrostatic | |||
| A:LYS31:HZ1 - B:GLN493:OE1 | 1.74 | Hydrogen Bond | |||
| A:TYR83:HH - B:ASN487:OD1 | 1.76 | Hydrogen Bond | |||
| B:ASN487:HD21 - A:GLN24:OE1 | 2.70 | Hydrogen Bond | |||
| B:THR500:HG1 - A:ASP355:OD2 | 1.85 | Hydrogen Bond | |||
| B:GLY502:HN - A:LYS353:O | 1.82 | Hydrogen Bond | |||
A: ACE2 B: SARS CoV-2 RBD.
Figure 7.The distance between the key interacting residue pairs i.e. ACE2 with RBD (SARS Cov-2) in wild type and mutant complexes during last 100 ns MD as a function of time. We only computed the distance between the interacting atom pairs of ACE2 and RBD forming electrostatic and hydrogen bonds.
Figure 8.Molecular interaction of wild type and mutant type complexes ACE2-RBD systems from MD trajectory. The top ranked snapshots extracted from the clustering analysis of the molecular dynamics trajectories were used for interaction analysis. (A) Interaction analysis of wild type and Y449 complex. (B) Intermolecular contacts of mutant N487, Y489A, N501 and Y505A complex systems. The hydrogen bond forming amino acids are colored in blue (ACE2) and green (RBD), respectively. The H-bonds are marked in green dotted lines along with their distance. Other non-bonded hydrophobic contact forming residues are labelled in semi-circles.
Figure 9.Saturation mutagenesis study depicting the effect of mutations at the interface of SARS-CoV-RBD-ACE2 (A) and SARS-CoV2-RBD-ACE2 (B). The interface residues are colored according to the average ΔΔGaffinity predictions values.